Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

559
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
559

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Machine-Learning Model for Accurate Diuresis Prediction in Acute Heart Failure (DRC-AHF).

ESC heart failure·2026
Same author

Balloon-Expandable Versus Self-Expanding Valves in Patients With Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same author

Acute kidney injury and renal function changes in cardiogenic shock.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

A Contemporary Perspective on Acute Decompensated Heart Failure Classification: A State-of-the-art Review from an International Expert Group.

Cardiac failure review·2026
Same author

Letter to the Editor: Reconsidering Contraindications for CardioMEMS in Congenital Heart Disease.

European journal of heart failure·2026
Same author

Real-world Sotatercept Eligibility: Analysis from the FOCUS-PAH Registry.

Respiration; international review of thoracic diseases·2026

相关实验视频

Updated: Jun 20, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

高强度护理GDMT定位的高强度护理

Jan Biegus1, Matteo Pagnesi2, Beth Davison3,4,5

  • 1Institute of Heart Diseases, Wroclaw Medical University, 50-556 Wroclaw, Borowska 213, Poland. jan.biegus@umw.edu.pl.

Heart failure reviews
|July 22, 2024
PubMed
概括

通过高强度护理优化心力衰竭 (HF) 患者的指导方针导向医疗疗 (GDMT) 改善了结果. 达到最佳的药物剂量对于有效管理HF和提高患者生活质量至关重要.

关键词:
GDMT (指南导向的医疗疗) 是指南导向的医疗疗.优化GDMT的优化方法药物治疗 药物治疗升级标称的升级标称.

更多相关视频

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.1K
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

10.9K

相关实验视频

Last Updated: Jun 20, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.1K
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

10.9K

科学领域:

  • 心脏病学 心脏病学
  • 药理学 药理学是指药理学的学科.
  • 内部医学 内部医学

背景情况:

  • 心力衰竭 (HF) 显著影响发病率,死亡率,住院和生活质量.
  • 有效的系统性治疗策略对于减轻HF风险至关重要.

研究的目的:

  • 强调高强度护理,以优化心力衰竭患者的指南导向医学治疗 (GDMT).
  • 突出实现最佳GDMT剂量的重要性,以改善患者的治疗结果.

主要方法:

  • 审查当前文献和临床实践指南的心力衰竭管理.
  • 强调GDMT的全面应用,包括特定的药物类别.

主要成果:

  • 优化GDMT (β-阻断剂,RAAS抑制剂,MRA,SGLT2抑制剂) 的剂量可以改善患者的治疗结果.
  • 有效的,可持续的减少拥堵和提高生活质量是优化GDMT的关键好处.
  • 对GDMT优化的障碍包括临床惯性,生理极限,并发症,不坚持和脆弱性.

结论:

  • 高强度护理和优化的GDMT对于管理心力衰竭至关重要.
  • 解决GDMT优化的障碍对于改善患者预后至关重要.
  • 未来的重症监护场景可能进一步加强心力衰竭管理.